SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,886,128 | +78.5% | 1,312,233 | 0.0% | 11.68% | +191.9% |
| Q2 2023 | $7,217,282 | -11.3% | 1,312,233 | 0.0% | 4.00% | +18.6% |
| Q1 2023 | $8,135,845 | -58.5% | 1,312,233 | +2.2% | 3.37% | -54.2% |
| Q4 2022 | $19,583,028 | +54.5% | 1,284,133 | +1.7% | 7.36% | +61.0% |
| Q3 2022 | $12,675,000 | – | 1,263,125 | – | 4.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,284,133 | $19,583,028 | 7.36% |
| TCG Crossover Management, LLC | 2,104,875 | $32,099,344 | 5.66% |
| M28 Capital Management LP | 145,900 | $2,224,975 | 2.12% |
| Lombard Odier Asset Management (Europe) Ltd | 3,218,200 | $49,077,550 | 1.99% |
| Lombard Odier Asset Management (USA) Corp | 3,875,734 | $50,594,057 | 1.29% |
| Deep Track Capital, LP | 1,951,580 | $29,761,595 | 1.25% |
| BVF INC/IL | 1,508,416 | $23,003,344 | 0.97% |
| Frazier Life Sciences Management, L.P. | 881,173 | $13,437,888 | 0.84% |
| Parkman Healthcare Partners LLC | 134,842 | $2,056,341 | 0.55% |
| CANTOR FITZGERALD, L. P. | 301,690 | $4,601 | 0.10% |